Answer
Zejula (niraparib tosylate monohydrate) is contraindicated in people with hypersensitivity to its active substance or any excipient listed in section 6.1.
Sources for this answer
- Zejula 100mg TabletsGlaxoSmithKline UK · emc · SmPC §4.3 Contraindications · Version 9Document updated
Sources checked